We are live on ! Find out more

FPRX

Five Prime Therapeutics, Inc.

FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

128 hedge funds and large institutions have $920M invested in Five Prime Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 43 increasing their positions, 42 reducing their positions, and 13 closing their positions.

New

Increased

Maintained

Reduced

Closed

160% more capital invested

Capital invested by funds: $354M → $920M (+$566M)

138% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 13

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

15% more funds holding

Funds holding: 111 → 128 (+17)

2% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 42

74% less call options, than puts

Call options by funds: $3.74M | Put options by funds: $14.4M

Holders

128

Holders Change

+17

Holders Change %

+15.32%

% of All Funds

3.36%

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

+66.67%

% of All Funds

0.13%

New

Increased

Reduced

Closed

Calls

$3.74M

Puts

$14.4M

Net Calls

-$10.7M

Net Calls Change

-$10M

Top Buyers

1	DM Deerfield Management New York	+$22.8M
2	EC EcoR1 Capital San Francisco, California	+$19.1M
3	RIM RS Investment Management San Francisco, California	+$17.1M
4	Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada	+$16.9M
5	BI BVF Inc San Francisco, California	+$10.1M

Top Sellers

1	State Street Boston, Massachusetts	-$28.9M
2	GPP Great Point Partners Greenwich, Connecticut	-$22M
3	RI RTW Investments New York	-$15.3M
4	GTC Ghost Tree Capital New York	-$13.4M
5	Adage Capital Partners Boston, Massachusetts	-$11.4M

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	26 Marshall Wace London, United Kingdom	$9.84M	+$2.39M	+71,262	+43%
27	27 Balyasny Asset Management Chicago, Illinois	$9.37M	-$3.7M	-110,365	-33%
28	28 Geode Capital Management Boston, Massachusetts	$7.62M	+$1.55M	+46,213	+34%
29	29 Goldman Sachs New York	$7.46M	+$4.78M	+142,719	+384%
30	TA 30 Teachers Advisors New York	$6.54M	+$112K	+3,329	+2%
31	31 Deutsche Bank Frankfurt Am Main Ge, Germany	$6.47M	+$2.27M	+67,740	+77%
32	32 Lord, Abbett & Co Jersey City, New Jersey	$6.33M	+$55.4K	+1,653	+1%
33	SFM 33 Sphera Funds Management Tel Aviv, Israel	$6.02M	-$1.01M	-30,000	-17%
34	TCIM 34 TIAA CREF Investment Management New York	$5.81M	-$115K	-3,433	-2%
35	SAM 35 Senzar Asset Management New York	$5.62M	+$4.54M	+135,535	New
36	RSCM 36 Rock Springs Capital Management Baltimore, Maryland	$5.6M	+$503K	+15,000	+13%
37	37 Bank of New York Mellon New York	$5.06M	+$339K	+10,113	+9%
38	AIC 38 AWM Investment Company New York	$4.91M	–	–	–
39	39 Wells Fargo San Francisco, California	$4.83M	-$73K	-2,179	-2%
40	CS 40 Candriam SCA Strassen, Luxembourg, Luxembourg	$4.62M	+$469K	+14,000	+14%
41	GTC 41 Ghost Tree Capital New York	$4.15M	-$13.4M	-400,000	-80%
42	42 AQR Capital Management Greenwich, Connecticut	$3.59M	-$1.47M	-43,965	-34%
43	BIM 43 BlackRock Investment Management Wilmington, Delaware	$3.23M	+$63K	+1,879	+2%
44	44 Allianz Asset Management Munich, Germany	$3.2M	-$42.3K	-1,261	-2%
45	HI 45 HBK Investments Dallas, Texas	$3.13M	+$1.91M	+56,900	+308%
46	GCP 46 GSA Capital Partners London, United Kingdom	$3M	+$238K	+7,086	+11%
47	BIM 47 Bogle Investment Management Newton Lower Falls, Massachusetts	$2.76M	+$2.23M	+66,477	New
48	BA 48 BlackRock Advisors Wilmington, Delaware	$2.36M	-$1.09M	-32,473	-36%
49	WMSA 49 Weiss Multi-Strategy Advisers New York	$2.28M	-$335K	-10,000	-15%
50	50 Macquarie Group Sydney, NSW 2000, Australia	$2.24M	+$201K	+5,990	+12%

FPRX Hedge Fund Activity: Q4 2015 in Review

128 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q4 2015, worth a combined $920M — up 160% from $354M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new FPRX positions and 13 closed out — a net gain of 18 holders — while 43 added to existing stakes and 42 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $22.8M. The largest seller was State Street, cutting an estimated $28.9M.

128 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q4 2015, up from 111 in Q3 2015.
Funds reported $920M of Five Prime Therapeutics, Inc. stock for Q4 2015, up 160% quarter-over-quarter.
31 funds opened new Five Prime Therapeutics, Inc. positions in Q4 2015 and 13 closed out, a net change of +18 holders.
The largest Five Prime Therapeutics, Inc. buyer in Q4 2015 was Deerfield Management, an estimated $22.8M added.
The largest Five Prime Therapeutics, Inc. seller in Q4 2015 was State Street, an estimated $28.9M sold.

Based on aggregated 13F filings for Q4 2015.

Five Prime Therapeutics, Inc. FPRX